Drug Trial Radar · NCT00412958
A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)
Last checked: Nov 20, 2026Latest source record: Dec 17, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
125
Actual
Start
Dec 2006
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- ThromboGenicsIndustry
- Sponsor type
- Industry
- First posted
- Dec 19, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multicenter study to compare multiple doses of intravitreal microplasmin in patients undergoing surgical vitrectomy.
Conditions
- Vitrectomy
Interventions
Ocriplasmin 25µgDrug
Intravitreal injection of 0.1 ml of ocriplasmin solution containing 25µg of ocriplasmin.
Ocriplasmin 75µgDrug
Intravitreal injection of 0.1 ml of ocriplasmin solution containing 75µg of ocriplasmin.
Ocriplasmin 125µgDrug
Intravitreal injection of 0.1 ml of ocriplasmin solution containing 125µg of ocriplasmin.
PlaceboDrug
Intravitreal injection of placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Patients Achieving Total Posterior Vitreous Detachment (PVD) Without Creation of an Anatomical DefectTime frame: Day 7
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Retina Centers, P.C.
Tucson, Arizona
VMR Institute
Huntington Beach, California
Jules Stein Eye Institute/UCLA
Los Angeles, California
Retinal Consultants of San Diego
Poway, California
Retinal Consultants Medical Group
Sacramento, California
National Ophtlamic Research Institute
Fort Meyers, Florida
Center for Retina and Macular Disease
Winter Haven, Florida
Rush University Med. Ctr
Chicago, Illinois
Mailing add: New England Eye Center - Tufts
Boston, Massachusetts
Associated Retinal Consultants, P.C.
Royal Oak, Michigan
Vitroretinal Surgery, PA
Minneapolis, Minnesota
Retina Vitreous Centre, PA
New Brunswick, New Jersey
Columbia University - Harkness Eye Institute
New York, New York
Retina Vitreous Surgeons of Central NY
New York, New York
Duke Eye Center
Durham, North Carolina
Retina Association of Cleveland
Lakewood, Ohio
Allegheny Ophthalmic & Orbital Associates, P.C.
Pittsburgh, Pennsylvania
Vanderbilt Eye Institute
Nashville, Tennessee
Vitreoretinal Consultants
Houston, Texas
Valley Retina Institute, P.A.
McAllen, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.